Cite
Impact of Post-progression Survival on Outcomes of Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma: A Systematic Review and Retrospective Cohort Study.
MLA
Tajiri, Kazuto, et al. “Impact of Post-Progression Survival on Outcomes of Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma: A Systematic Review and Retrospective Cohort Study.” Anticancer Research, vol. 42, no. 12, Dec. 2022, pp. 6007–18. EBSCOhost, https://doi.org/10.21873/anticanres.16112.
APA
Tajiri, K., Tokimitsu, Y., Kawai, K., Motofuji, Y., Shinno, E., Kashii, Y., Muraishi, N., Murayama, A., Hayashi, Y., Minemura, M., Takahara, T., Shimizu, Y., & Yasuda, I. (2022). Impact of Post-progression Survival on Outcomes of Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma: A Systematic Review and Retrospective Cohort Study. Anticancer Research, 42(12), 6007–6018. https://doi.org/10.21873/anticanres.16112
Chicago
Tajiri, Kazuto, Yoshiharu Tokimitsu, Kengo Kawai, Yuchi Motofuji, Eiji Shinno, Yoshiro Kashii, Nozomu Muraishi, et al. 2022. “Impact of Post-Progression Survival on Outcomes of Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma: A Systematic Review and Retrospective Cohort Study.” Anticancer Research 42 (12): 6007–18. doi:10.21873/anticanres.16112.